Global Glaucoma Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431882
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Aerie Pharmaceuticals
  • Akorn, Inc.
  • Allergan plc.
  • Inotek Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • MORE
Glaucoma Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Glaucoma Therapeutics market was valued at US$ 4.42 Bn in 2016, and is expected to reach US$ 5.67 Bn by 2025, expanding at a CAGR of 2.8% from 2017 to 2025.

Market Insights

Glaucoma is chronic, degenerative disorder that damages the eye's optic nerve that may result in vision loss and blindness. Glaucoma therapeutics is rapidly growing due to factors such as increase in prevalence of eye disorders around the world, significant unmet needs and rise in the incidence of age-related eye diseases contributing to the market growth of glaucoma therapeutics globally. For the purpose of study, global glaucoma therapeutics market is segmented on the basis of drug class such as prostaglandins analogs, beta blockers, alpha-adrenergic agonists, carbonic anhydrase inhibitors and fixed-dose combinations. It is observed that, in the base year 2016, prostaglandins analogs t was the highest contributing market segment. Prostaglandins analogs generally are given as first line therapy and higher adherence to the treatment are driving the market growth of prostaglandins analogs worldwide. Glaucoma therapeutics market is currently dominated by North America - . Factors such as higher cost of therapy and glaucoma being the second leading cause of blindness in the US are the factors driving the market growth in North America. Currently, Asia Pacific is not major revenue generating segment it is anticipated that Asia Pacific will show highest CAGR during forecast period. Factors such as increasing healthcare awareness, continuous economic development and developing healthcare infrastructure would drive the market growth during forecast period.

Market Competition Assessment

The Glaucoma Therapeutics market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Aerie Pharmaceuticals, Akorn, Inc., Allergan plc., Bausch & Lomb Incorporated, Inotek Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer Inc., Santen Pharmaceuticals Co. Ltd., Teva Pharmaceuticals and other.

Key Market Movements:
  • Factors such as higher prevalence glaucoma disorder, increasing public awareness for treatment, improved diagnostic techniques, favorable reimbursement policies in some countries and high degree of R&D activity in development of glaucoma therapeutics are driving the market growth.
  • Due to the high unmet needs, vendors in the market are focusing on innovation and technological advances in treatment, this would further influence the market growth of glaucoma therapeutics globally.
  • However, patent expiry of major approved drugs leads to generic erosion, poor patient compliance to medication and adverse effects associated with the use of medication which would negatively impacting market growth of glaucoma therapeutics.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Aerie Pharmaceuticals
  • Akorn, Inc.
  • Allergan plc.
  • Inotek Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Glaucoma Therapeutics Market Snapshot
2.2 Global Glaucoma Therapeutics Market, by Drug Class, 2016 (US$ Bn)
2.3 Global Glaucoma Therapeutics Market Share, by Geography, 2016 (Value %)

Chapter 3 Glaucoma Therapeutics Market Analysis
3.1 Global Glaucoma Therapeutics Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Significant Unmet Need
3.2.1.2 High prevalence of Eye Disorders
3.2.2 Challenges
3.2.2.1 Poor Patient Compliance
3.2.3 Opportunities
3.2.3.1 Increasing Treatment Awareness
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Glaucoma Therapeutics Market

Chapter 4 Global Glaucoma Therapeutics Market, by Drug Class
4.1 Overview
4.2 Prostaglandins Analogs
4.3 Beta Blockers
4.4 Alpha-adrenergic Agonists
4.5 Carbonic Anhydrase Inhibitors
4.6 Fixed-dose Combinations

Chapter 5 Global Glaucoma Therapeutics Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.3 Europe (U.K., Germany & Rest of Europe)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.5 Latin America
5.6 Middle East and Africa

Chapter 6 Company Profiles
6.1 Aerie Pharmaceuticals
6.2 Akorn, Inc.
6.3 Allergan plc.
6.4 Bausch & Lomb Incorporated
6.5 Inotek Pharmaceuticals
6.6 Merck & Co., Inc.
6.7 Novartis AG
6.8 Pfizer Inc.
6.9 Santen Pharmaceuticals Co. Ltd
6.10 Teva Pharmaceuticals

List of Figures
Fig. 1 Glaucoma Therapeutics Market: Research Methodology
Fig. 2 Global Glaucoma Therapeutics Market, by Drug Class, 2016 (US$ Bn)
Fig. 3 Global Glaucoma Therapeutics Market Share, by Geography, 2016 (Value %)
Fig. 4 Attractive Investment Proposition: Global Glaucoma Therapeutics Market, by Geography, 2016
Fig. 5 Global Prostaglandins Analogs Market for Glaucoma Therapeutics, 2015 - 2025 (US$ Bn)
Fig. 6 Global Beta Blockers Market for Glaucoma Therapeutics, 2015 - 2025 (US$ Bn)
Fig. 7 Global Alpha-adrenergic Agonists Market for Glaucoma Therapeutics, 2015 - 2025 (US$ Bn)
Fig. 8 Global Carbonic Anhydrase Inhibitors Market for Glaucoma Therapeutics, 2015 - 2025 (US$ Bn)
Fig. 9 Global Fixed-dose Combinations Market for Glaucoma Therapeutics, 2015 - 2025 (US$ Bn)
Fig. 10 Latin America Glaucoma Therapeutics Market, 2015 - 2025 (US$ Bn)
Fig. 11 Middle East and Africa Glaucoma Therapeutics Market, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Glaucoma Therapeutics Market
Table 2 Global Glaucoma Therapeutics Market, by Drug Class, 2015 - 2025 (US$ Bn)
Table 3 Global Glaucoma Therapeutics Market, by Geography, 2015 - 2025 (US$ Bn)
Table 4 North America Glaucoma Therapeutics Market, by Country, 2015 - 2025 (US$ Bn)
Table 5 Europe Glaucoma Therapeutics Market, by Country, 2015 - 2025 (US$ Bn)
Table 6 Asia Pacific Glaucoma Therapeutics Market, by Country, 2015 - 2025 (US$ Bn)
Table 7 Aerie Pharmaceuticals
: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 8 Akorn, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 9 Allergan plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 10 Bausch & Lomb Incorporated: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 Inotek Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Santen Pharmaceuticals Co. Ltd: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 Teva Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Aerie Pharmaceuticals
  • Akorn, Inc.
  • Allergan plc.
  • Bausch & Lomb Incorporated
  • Inotek Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Santen Pharmaceuticals Co. Ltd
  • Teva Pharmaceuticals
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll